Dr. Iram Nawaz, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 211 Fountain Ct Ste 210, Lexington, KY 40509 Phone: 859-629-7145 Fax: 859-276-5939 |
News Archive
First Lady Michelle Obama joined Secretary of State Hillary Rodham Clinton to mark International Women's Day on Tuesday by honoring recent gains in addressing global women's issues while reflecting on the scope of the task of achieving gender equity in the future, the Associated Press reports.
Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The trial, conducted at the University of California, San Diego ("UCSD") General Clinical Research Center, evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of DR Cysteamine in nine cystinosis patients.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
› Verified 9 days ago